Who makes Goldnatriomthiosulphate, MDBGN, parthenolide?

Goldnatriomthiosulphate, MDBGN, parthenolide is developed by Mekos Laboratories AS.

What development phase is Goldnatriomthiosulphate, MDBGN, parthenolide in?

Goldnatriomthiosulphate, MDBGN, parthenolide is in Phase 2.

Last reviewed 2026-04-23 · How we verify

Goldnatriomthiosulphate, MDBGN, parthenolide

Mekos Laboratories AS · Phase 2 active Small molecule

At a glance

Generic name	Goldnatriomthiosulphate, MDBGN, parthenolide
Sponsor	Mekos Laboratories AS
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Goldnatriomthiosulphate, MDBGN, parthenolide CI brief — competitive landscape report
Goldnatriomthiosulphate, MDBGN, parthenolide updates RSS · CI watch RSS
Mekos Laboratories AS portfolio CI